Quick answer: The most common side effects of injectable GLP-1 weight-loss medications are nausea, diarrhea, vomiting and constipation, particularly when starting or increasing a dose. Smaller meals, hydration and individualized dose management may help. Severe or persistent abdominal pain, dehydration or signs of an allergic reaction require prompt medical evaluation. [1–3]
Nausea after a dose increase? Constipation that won’t quit? Worried about hair shedding or “Ozempic face”? These concerns are common—and deserve more than a quick prescription refill. Most GLP-1 gastrointestinal side effects are manageable, but some symptoms need prompt medical attention. Knowing the difference helps you use treatment more safely.
The essentials: Eat smaller meals, hydrate consistently, communicate symptoms early, and never increase your dose simply because the calendar says it is time. Severe or persistent symptoms should be evaluated—not ignored. [1–3]
1. Which Side Effects Are Most Common?
For injectable Wegovy (semaglutide 2.4 mg), obesity trials reported nausea in 44% of treated adults, diarrhea in 30%, vomiting in 24%, and constipation in 24%. With Zepbound (tirzepatide), common reactions varied by dose: nausea in 25–29%, diarrhea in 19–23%, vomiting in 8–13%, and constipation in 11–17%. These are results from different trials, not a head-to-head comparison and not estimates for every GLP-1 formulation. [1, 2]
| Common symptom | What it can feel like | First step |
|---|---|---|
| Nausea / early fullness | Queasiness, appetite changes, discomfort after large meals | Smaller, slower meals; avoid heavy/fatty foods. |
| Constipation | Hard or infrequent stools, bloating | Fluids, appropriate fiber and movement; ask about a bowel plan. |
| Diarrhea / vomiting | Loose stools, poor fluid tolerance | Replace fluids; contact your care team if persistent. |
| Reflux / burping | Heartburn or upper-abdominal fullness | Avoid large late meals; discuss persistent symptoms. |
Symptoms often appear when treatment starts or the dose increases, and some improve as the body adjusts. [1–3]
2. How to Manage Nausea Without Losing Nutritional Ground
- Eat modest portions more frequently; stop when comfortably full rather than trying to finish a large plate.
- Choose simple, lower-fat foods on difficult days. A small breakfast and regular, manageable meals can be easier than prolonged fasting.
- Sip fluids throughout the day. If you cannot keep fluids down, call your medical team.
- Tell your prescriber before the next dose increase if symptoms have not settled. Your clinician may delay escalation or adjust the treatment plan.
Persistent nausea can create a cycle: eat less, feel worse, then struggle to meet protein and fluid needs. A personalized nutrition plan helps protect your overall health while you lose weight. [3]
3. Constipation, Diarrhea and Reflux: Small Adjustments Matter
Constipation often responds to better hydration, gradually appropriate dietary fiber and activity. However, suddenly adding large quantities of fiber while already bloated may make discomfort worse. Ask your clinician whether a fiber supplement or an over-the-counter bowel regimen is appropriate for you, particularly if you have kidney disease or take multiple medications. [3]
For diarrhea or reflux, avoid large high-fat meals and consider smaller portions. Ongoing diarrhea, repeated vomiting, dizziness or dark urine may signal dehydration and require medical assessment. Never treat severe abdominal pain as routine constipation.
4. What About Hair Loss and “Ozempic Face”?
Hair shedding can occur with substantial or rapid weight loss and sometimes reflects telogen effluvium, inadequate protein intake or nutritional deficiencies. Hair loss was reported in 4–5% of Zepbound-treated adults across dose groups in pooled obesity trials. A clinician can assess whether weight-loss pace, protein intake, iron status, thyroid disease or another cause may be contributing. [2]
“Ozempic face” is a popular term for facial volume loss that can accompany weight reduction; it is not a distinct drug-specific diagnosis. Focus first on a sustainable rate of weight loss, balanced nutrition and strength training—not cosmetic claims or supplements promising to reverse it.
5. When to Call—and When to Seek Urgent Care
| Call your medical team promptly | Seek urgent / emergency assessment |
|---|---|
| Nausea that persists or prevents normal eating; repeated vomiting; constipation that does not improve; troublesome reflux. | Severe, persistent abdominal pain—especially if it radiates to your back, with or without vomiting (possible pancreatitis). |
| Dizziness, reduced urine output, or difficulty staying hydrated; new or worsening abdominal symptoms. | Severe right-upper-abdominal pain with fever or yellowing of the skin/eyes (possible gallbladder complication). |
| Hair shedding or fatigue that may reflect inadequate nutrition; symptomatic low blood sugar if using insulin or a sulfonylurea. | Swelling of the face or throat, difficulty breathing, or a severe allergic reaction; fainting or inability to keep fluids down. |
GLP-1 medicines also have important precautions involving delayed gastric emptying and anesthesia, pregnancy, and a boxed warning related to thyroid C-cell tumors observed in rodents. Tell your treating clinicians about these medicines before procedures. Do not use them if you have a personal or family history of medullary thyroid carcinoma or MEN2. Specific product labeling and individualized assessment matter. [1, 2]
6. Why Medical Oversight Matters at Achieve
At Achieve Health & Weight Loss, medication is only one part of treatment. Our physician-supervised virtual program combines medical management, one-on-one coaching every two weeks, connected body-composition monitoring, and ongoing support for nutrition, movement and accountability. That approach gives members a way to flag side effects early, review their progress and make medically appropriate adjustments. [4]
Our goal is not simply to help you tolerate a higher dose. It is to identify a treatment plan you can use safely while maintaining hydration, adequate nutrition, strength and long-term habits. No medication works equally well for everyone, and treatment decisions should be individualized.
Frequently Asked Questions
Do GLP-1 side effects go away?
For many people, nausea and other gastrointestinal effects lessen over time, especially after the body adjusts to a dose. Persistent or severe effects need clinical review; do not assume they will simply resolve.
Should I skip meals if I feel nauseated?
Prolonged fasting can worsen nausea for some patients and make adequate protein and fluid intake difficult. Smaller, simple meals are often easier, but individualized guidance matters.
Can I take something for constipation?
Possibly. Your medical team can review fluids, diet, current medicines and whether an appropriate over-the-counter option is safe for you.
Does hair loss mean the medication is damaging my hair?
Not necessarily. Weight change, low intake and other medical causes can contribute. Discuss new or substantial shedding with your clinician.
Should I stop the medication if I have abdominal pain?
Severe or persistent abdominal pain requires urgent medical evaluation. Contact your prescriber for instructions and do not take another dose until clinically advised if pancreatitis is suspected.
A Better Weight-Loss Plan Includes a Plan for Side Effects
You should never have to guess whether a symptom is expected or serious. Achieve pairs individualized medical care with personalized coaching and accountability, helping members focus on both effective weight loss and their overall health. If your progress has stalled rather than your stomach, read our guide to GLP-1 weight-loss plateaus.
Medical disclaimer: Educational content only; not individualized medical advice. Never change, stop or escalate prescribed medication without guidance from your prescribing clinician. In a medical emergency, call 911. Updated September 2026.
References
- DailyMed. Wegovy (semaglutide) prescribing information. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
- Eli Lilly. Zepbound (tirzepatide) U.S. prescribing information, revised 2026. https://uspl.lilly.com/zepboundsp/zepboundsp-pi.pdf
- Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory. American Journal of Clinical Nutrition. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12264624/
- Achieve Health & Weight Loss. Concierge weight management program, medical oversight, coaching and connected monitoring. https://joinachievehealth.com/
